Log In
BCIQ
Print this Print this
 

Simplexa Flu A/B & RSV test

  Manage Alerts
Collapse Summary General Information
Company Quest Diagnostics Inc.
Descriptionin vitro real-time reverse transcription (RT)-PCR assay to qualitatively detect RNA in a patient's nasal or nasopharyngeal specimen
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDiagnose and discriminate influenza A, influenza B and RSV infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$300.0M

$300.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/30/2016

$300.0M

$300.0M

0

Get a free BioCentury trial today